methylthio-adp has been researched along with prasugrel in 2 studies
| Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) | Studies (prasugrel) | Trials (prasugrel) | Recent Studies (post-2010) (prasugrel) |
|---|---|---|---|---|---|
| 146 | 2 | 43 | 18 | 0 | 16 |
| Protein | Taxonomy | methylthio-adp (IC50) | prasugrel (IC50) |
|---|---|---|---|
| P2Y purinoceptor 12 | Homo sapiens (human) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, HM; Camden, J; Fischer, B; Shai, E; Varon, D; Weisman, GA; Yelovitch, S | 1 |
| Chen, B; Danon, JJ; Kassiou, M; Ma, BB; Montgomery, AP | 1 |
1 review(s) available for methylthio-adp and prasugrel
| Article | Year |
|---|---|
Strategies for targeting the P2Y
Topics: Central Nervous System; Ligands; Microglia; Platelet Aggregation; Receptors, Purinergic P2Y12; Signal Transduction | 2022 |
1 other study(ies) available for methylthio-adp and prasugrel
| Article | Year |
|---|---|
Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.
Topics: Animals; Blood Glucose; Cell Line, Tumor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Molecular Structure; Purinergic P2Y Receptor Agonists; Rats; Rats, Wistar | 2012 |